Free Trial

Calamos Advisors LLC Takes Position in Lifevantage Corporation (NASDAQ:LFVN)

Lifevantage logo with Medical background

Calamos Advisors LLC acquired a new position in shares of Lifevantage Corporation (NASDAQ:LFVN - Free Report) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 33,576 shares of the company's stock, valued at approximately $490,000. Calamos Advisors LLC owned 0.27% of Lifevantage at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in LFVN. Cannon Global Investment Management LLC acquired a new position in shares of Lifevantage in the first quarter worth about $156,000. Cambridge Investment Research Advisors Inc. increased its stake in shares of Lifevantage by 23.2% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 12,867 shares of the company's stock valued at $188,000 after purchasing an additional 2,421 shares in the last quarter. Hillsdale Investment Management Inc. boosted its position in Lifevantage by 7.3% during the fourth quarter. Hillsdale Investment Management Inc. now owns 14,720 shares of the company's stock worth $258,000 after purchasing an additional 1,000 shares in the last quarter. Schonfeld Strategic Advisors LLC purchased a new position in Lifevantage during the fourth quarter worth approximately $282,000. Finally, OMERS ADMINISTRATION Corp acquired a new stake in Lifevantage in the fourth quarter valued at approximately $284,000. 35.32% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, CFO Carl Aure sold 2,746 shares of the business's stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $13.39, for a total value of $36,768.94. Following the sale, the chief financial officer owned 133,303 shares in the company, valued at approximately $1,784,927.17. The trade was a 2.02% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 20.65% of the company's stock.

Lifevantage Trading Down 0.9%

LFVN traded down $0.13 during midday trading on Monday, hitting $13.59. 133,040 shares of the company traded hands, compared to its average volume of 155,382. The business has a 50 day simple moving average of $12.56 and a two-hundred day simple moving average of $15.91. Lifevantage Corporation has a 52-week low of $5.22 and a 52-week high of $27.38. The company has a market capitalization of $171.10 million, a price-to-earnings ratio of 19.70 and a beta of 0.43.

Lifevantage (NASDAQ:LFVN - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $0.26 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.16 by $0.10. The firm had revenue of $58.44 million during the quarter, compared to analyst estimates of $60.99 million. Lifevantage had a net margin of 4.12% and a return on equity of 34.67%.

Lifevantage Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, June 13th. Shareholders of record on Friday, May 30th were given a dividend of $0.045 per share. The ex-dividend date of this dividend was Friday, May 30th. This is a boost from Lifevantage's previous quarterly dividend of $0.04. This represents a $0.18 dividend on an annualized basis and a dividend yield of 1.32%. Lifevantage's dividend payout ratio (DPR) is currently 26.09%.

Lifevantage Profile

(Free Report)

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.

Read More

Institutional Ownership by Quarter for Lifevantage (NASDAQ:LFVN)

Should You Invest $1,000 in Lifevantage Right Now?

Before you consider Lifevantage, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lifevantage wasn't on the list.

While Lifevantage currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Made in America Stocks Under $20 You Need to See!
3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines